NFE2L2 and glioblastoma: After isolating GBM cells based on this marker, the study found Nrf2 to be overexpressed in CD133+ GBM stem cells in comparison with CD133− stem cells, indicating that Nrf-2 expression could be contributing to the malignant proliferation and differentiation of GBM stem cells [20].